0001950047-24-000258.txt : 20240110 0001950047-24-000258.hdr.sgml : 20240110 20240110161129 ACCESSION NUMBER: 0001950047-24-000258 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 24526717 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Dorling Janet CENTRAL INDEX KEY: 0001738144 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ACHAOGEN, INC. STREET 2: 1 TOWER PLACE, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001738144 XXXXXXXX LIVE 0001042074 CYMABAY THERAPEUTICS, INC. 001-36500 7575 Gateway Blvd, Suite 110 Newark CA 94560 (510) 293-8800 JANET DORLING Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

6000 143143.80 113403353 01/10/2024 NASDAQ COMMON 01/10/2024 Stock Option Exercise ISSUER N 6000 01/10/2024 Cash N JANET DORLING

7575 Gateway Blvd, Suite 110 Newark CA 94560

Common 12/11/2023 6000 120421.80 JANET DORLING

7575 Gateway Blvd, Suite 110 Newark CA 94560

Common 11/10/2023 7000 106699.60 01/10/2024 08/09/2023 /s/ Janet Dorling